Clinical features and immune memory of breakthrough infection in children after age-appropriate 13-valent pneumococcal conjugate vaccination in Taiwan

Lu CY, Chiang CS, Chiu CH, Wang ET, Chen YY, Yao SM, et al. Successful control of Streptococcus pneumoniae 19A replacement with a catch-up primary vaccination program in Taiwan. Clin Infect Dis. 2019;69:1581–7. https://doi.org/10.1093/cid/ciy1127.

Article  PubMed  Google Scholar 

Chen CH, Janapatla RP, Su LH, Li HC, Kuo KC, Chien CC, Hsiao CC, Chiu CH. Incidence rates, emerging serotypes and genotypes, and antimicrobial susceptibility of pneumococcal disease in Taiwan: a multi-center clinical microbiological study after PCV13 implementation. J Infect. 2022;84(6):788–94. https://doi.org/10.1016/j.jinf.2022.04.022.

Article  PubMed  CAS  Google Scholar 

Janapatla RP, Hsu MH, Chen CL, Wei SH, Yu MJ, Su LH, et al. Persistence of immunity in children immunised with 13-valent pneumococcal conjugate vaccine and impact on nasopharyngeal carriage: a cross-sectional study. Thorax. 2020;75:689–92. https://doi.org/10.1136/thoraxjnl-2019-213878.

Article  PubMed  Google Scholar 

Chen CH, Chen CL, Arguedas A, Southern J, Hsiao CC, Chiu CH. Divergent serotype distribution between children with otitis media and those without in the pneumococcal conjugate vaccine era. J Microbiol Immunol Infect. 2020;53:1035–8. https://doi.org/10.1016/j.jmii.2020.05.003.

Article  PubMed  CAS  Google Scholar 

Chapman TJ, Pichichero ME, Kaur R. Comparison of pneumococcal conjugate vaccine (PCV-13) cellular immune responses after primary and booster doses of vaccine. Hum Vaccin Immunother. 2020;16:3201–7. https://doi.org/10.1080/21645515.2020.1753438.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Farmaki PF, Chini MC, Mangafas NM, Tzanoudaki MT, Piperi CP, Lazanas MZ, et al. Immunogenicity and immunological memory induced by the 13-valent pneumococcal conjugate followed by the 23-valent polysaccharide vaccine in HIV-infected adults. J Infect Dis. 2018;218:26–34. https://doi.org/10.1093/infdis/jiy135.

Article  PubMed  CAS  Google Scholar 

Papadatou I, Tzovara I, Licciardi PV. The role of serotype-specific immunological memory in pneumococcal vaccination: current knowledge and future prospects. Vaccines (Basel). 2019;7:13. https://doi.org/10.3390/vaccines7010013.

Article  PubMed  CAS  Google Scholar 

Pennington SH, Pojar S, Mitsi E, Gritzfeld JF, Nikolaou E, Solórzano C, et al. Polysaccharide-specific memory B cells predict protection against experimental human pneumococcal carriage. Am J Respir Crit Care Med. 2016;194:1523–31. https://doi.org/10.1164/rccm.201512-2467oc.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Swarthout TD, Henrion MYR, Thindwa D, Meiring JE, Mbewe Maurice KO, Akuzike, et al. Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study. Lancet Infect Dis. 2022;22:1737–47. https://doi.org/10.1016/s1473-3099(22)00438-8.

Oligbu G, Hsia Y, Folgori L, Collins S, Ladhani S. Pneumococcal conjugate vaccine failure in children: a systematic review of the literature. Vaccine. 2016;34:6126–32. https://doi.org/10.1016/j.vaccine.2016.10.050.

Article  PubMed  CAS  Google Scholar 

Pneumococcal vaccination. Summary of who and when to vaccinate. Available at https://www.cdc.gov/vaccines/vpd/pneumo/hcp/who-when-to-vaccinate.html. [Accessed November 11, 2023].

Wernette CM, Frasch CE, Madore D, Carlone G, Goldblatt D, Plikaytis B, et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol. 2003;10:514–9. https://doi.org/10.1128/cdli.10.4.514-519.2003.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Andrews N, Kent A, Amin-Chowdhury Z, Sheppard C, Fry N, Ramsay M, et al. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: the indirect cohort design, 2006–2018. Vaccine. 2019;37:4491–8. https://doi.org/10.1016/j.vaccine.2019.06.071.

Article  PubMed  Google Scholar 

Adebanjo TA, Pondo T, Yankey D, Hill HA, Gierke R, Apostol M, et al. Pneumococcal conjugate vaccine breakthrough infections: 2001–2016. Pediatrics. 2020;145:e20190836. https://doi.org/10.1542/peds.2019-0836.

Article  PubMed  Google Scholar 

Bertran M, D’Aeth JC, Abdullahi F, Eletu S, Andrews NJ, Ramsay ME et al. Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study. Lancet Infect Dis 2024 Feb 1:S1473–3099(23)00706–5. https://doi.org/10.1016/S1473-3099(23)00706-5

Silva-Costa C, Gomes-Silva J, Pinho MD, Friães A, Ramirez M, Melo-Cristino J. Continued vaccine breakthrough cases of serotype 3 complicated pneumonia in vaccinated children, Portugal (2016–2019). Microbiol Spectr. 2022;10:e0107722. https://doi.org/10.1128/spectrum.01077-22.

Article  PubMed  CAS  Google Scholar 

Ricketson LJ, Bettinger JA, Sadarangani M, Halperin SA, Kellner JD. Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: an IMPACT study. Vaccine. 2022;40:2733–40. https://doi.org/10.1016/j.vaccine.2022.03.048.

Article  PubMed  CAS  Google Scholar 

Mungall BA, Hoet B, Nieto Guevara J, Soumahoro L. A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children. Expert Rev Vaccines. 2022;21:201–14. https://doi.org/10.1080/14760584.2022.2012455.

Article  PubMed  CAS  Google Scholar 

Andrews NJ, Waight PA, Burbidge P, Pearce E, Roalfe L, Zancolli M, et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis. 2014;14:839–46. https://doi.org/10.1016/s1473-3099(14)70822-9.

Article  PubMed  CAS  Google Scholar 

Siber GR, Chang I, Baker S, Fernsten P, O’Brien KL, Santosham M, et al. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine. 2007;25:3816–26. https://doi.org/10.1016/j.vaccine.2007.01.119.

Article  PubMed  CAS  Google Scholar 

Lee HY, Hsieh YC, Liu CC, Huang YC, Chang KY, Chi H, et al. Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules. J Microbiol Immunol Infect. 2018;51:199–206. https://doi.org/10.1016/j.jmii.2017.08.022.

Article  PubMed  Google Scholar 

Wysocki J, Brzostek J, Szymański H, Tetiurka B, Toporowska-Kowalska E, Wasowska-Królikowska K, et al. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naïve to pneumococcal vaccination. Vaccine. 2015;33:1719–25. https://doi.org/10.1016/j.vaccine.2015.02.005.

Article  PubMed  CAS  Google Scholar 

Trück J, Thompson A, Morales-Aza B, Clutterbuck EA, Voysey M, Clarke E, et al. Memory B cell response to a PCV-13 booster in 3.5 year old children primed with either PCV-7 or PCV-13. Vaccine. 2017;35:2701–8. https://doi.org/10.1016/j.vaccine.2017.03.079.

Article  PubMed  CAS  Google Scholar 

Kurosaki T, Kometani K, Ise W. Memory B cells. Nat Rev Immunol. 2015;15(3):149–59. https://doi.org/10.1038/nri3802.

Article  PubMed  CAS  Google Scholar 

Pape KA, Taylor JJ, Maul RW, Gearhart PJ, Jenkins MK. Different B cell populations mediate early and late memory during an endogenous immune response. Science. 2011;331:1203–7. https://doi.org/10.1126/science.1201730.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Micoli F, Romano MR, Carboni F, Adamo R, Berti F. Strengths and weaknesses of pneumococcal conjugate vaccines. Glycoconj J. 2023;40:135–48. https://doi.org/10.1007/s10719-023-10100-3.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dagan R, Patterson S, Juergens C, Greenberg D, Givon-Lavi N, Porat N, et al. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin Infect Dis. 2013;57:952–62. https://doi.org/10.1093/cid/cit428.

Article  PubMed  CAS  Google Scholar 

留言 (0)

沒有登入
gif